CD30+, large T-cell lymphoma: diagnostic distinction and management.
Cutaneous T-cell lymphoma (CTCL) has a variable presentation and comprises a broad diagnostic group. Histologic and immunophenotypic confirmation is needed to establish a precise diagnosis. Once the categorization is determined, prognosis and therapeutic algorithms unfold. Primary cutaneous, CD-30+, anaplastic, large T-cell lymphoma represents an indolent form of CTCL that often spontaneously involutes.
Parlette
Eric C
EC
Uniformed Services University of Health Sciences, Department of Dermatology, US Naval Hospital, Okinawa, Japan. ecparlette@yahoo.com
Tabor
Camille A
CA
D000368:Aged; D015703:Antigens, CD / Q000032:analysis; D002990:Clobetasol / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D017728:Lymphoma, Large-Cell, Anaplastic / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D012074:Remission Induction; D012075:Remission, Spontaneous; D013848:Thigh
D015703:Antigens, CD; D002990:Clobetasol